The strength of corticomotoneuronal drive underlies ALS split phenotypes and reflects early upper motor neuron dysfunction.
amyotrophic lateral sclerosis
corticomotoneuronal
corticomuscular coherence
excitatory post-synaptic potential
neuroimaging
split phenotypes
Journal
Brain and behavior
ISSN: 2162-3279
Titre abrégé: Brain Behav
Pays: United States
ID NLM: 101570837
Informations de publication
Date de publication:
12 2021
12 2021
Historique:
revised:
02
09
2021
received:
05
07
2021
accepted:
05
10
2021
pubmed:
29
10
2021
medline:
15
3
2022
entrez:
28
10
2021
Statut:
ppublish
Résumé
Split phenotypes, (split hand, elbow, leg, and foot), are probably unique to ALS, and are characterized by having a shared peripheral input of both affected and unaffected muscles. This implies an anatomical origin rostral to the spinal cord, primarily within the cerebral cortex. Therefore, split phenotypes are a potential marker of ALS upper motor neuron pathology. However, to date, reports documenting upper motor neuron dysfunction in split phenotypes have been limited to using transcranial magnetic stimulation and cortical threshold tracking techniques. Here, we consider several other potential methodologies that could confirm a primary upper motor neuron pathology in split phenotypes. We review the potential of: 1. measuring the compound excitatory post-synaptic potential recorded from a single activated motor unit, 2. cortical-muscular coherence, and 3. new advanced modalities of neuroimaging (high-resolution imaging protocols, ultra-high field MRI platforms [7T], and novel Non-Gaussian diffusion models). We propose that muscles involved in split phenotypes are those functionally involved in the human motor repertoire used particularly in complex activities. Their anterior horn cells receive the strongest corticomotoneuronal input. This is also true of the weakest muscles that are the earliest to be affected in ALS. Descriptions of split hand in non-ALS cases and proposals that peripheral nerve or muscle dysfunction may be causative are contentious. Only a few carefully controlled cases of each form of split phenotype, using upper motor neuron directed methodologies, are necessary to prove our postulate.
Sections du résumé
BACKGROUND
Split phenotypes, (split hand, elbow, leg, and foot), are probably unique to ALS, and are characterized by having a shared peripheral input of both affected and unaffected muscles. This implies an anatomical origin rostral to the spinal cord, primarily within the cerebral cortex. Therefore, split phenotypes are a potential marker of ALS upper motor neuron pathology. However, to date, reports documenting upper motor neuron dysfunction in split phenotypes have been limited to using transcranial magnetic stimulation and cortical threshold tracking techniques. Here, we consider several other potential methodologies that could confirm a primary upper motor neuron pathology in split phenotypes.
METHODS
We review the potential of: 1. measuring the compound excitatory post-synaptic potential recorded from a single activated motor unit, 2. cortical-muscular coherence, and 3. new advanced modalities of neuroimaging (high-resolution imaging protocols, ultra-high field MRI platforms [7T], and novel Non-Gaussian diffusion models).
CONCLUSIONS
We propose that muscles involved in split phenotypes are those functionally involved in the human motor repertoire used particularly in complex activities. Their anterior horn cells receive the strongest corticomotoneuronal input. This is also true of the weakest muscles that are the earliest to be affected in ALS. Descriptions of split hand in non-ALS cases and proposals that peripheral nerve or muscle dysfunction may be causative are contentious. Only a few carefully controlled cases of each form of split phenotype, using upper motor neuron directed methodologies, are necessary to prove our postulate.
Identifiants
pubmed: 34710283
doi: 10.1002/brb3.2403
pmc: PMC8671797
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2403Informations de copyright
© 2021 The Authors. Brain and Behavior published by Wiley Periodicals LLC.
Références
J Physiol. 1992 Mar;448:397-412
pubmed: 1593472
AJNR Am J Neuroradiol. 2012 Aug;33(7):1274-80
pubmed: 22460344
Neurosci Lett. 2014 Jan 13;558:192-6
pubmed: 24275213
J Neurosci. 1997 Jan 1;17(1):251-66
pubmed: 8987753
Ann Neurol. 2021 May;89(5):979-986
pubmed: 33565111
Exp Brain Res. 2002 Mar;143(1):51-6
pubmed: 11907690
J Magn Reson Imaging. 2021 Jan;53(1):223-233
pubmed: 32896088
Can J Physiol Pharmacol. 1990 Sep;68(9):1231-5
pubmed: 2276086
Muscle Nerve. 2009 Mar;39(3):350-4
pubmed: 19208410
J Physiol. 1995 Dec 15;489 ( Pt 3):917-24
pubmed: 8788955
J Neurol. 2015 Jun;262(6):1424-32
pubmed: 25845764
J Neurosurg. 2011 Jun;114(6):1706-14
pubmed: 21375376
Front Neurosci. 2019 May 22;13:522
pubmed: 31178688
Neuroimage. 2017 Oct 1;159:403-416
pubmed: 28782683
Muscle Nerve. 2008 Apr;37(4):426-30
pubmed: 18236469
Amyotroph Lateral Scler Frontotemporal Degener. 2019 Aug;20(5-6):368-375
pubmed: 31056952
J Neurol. 2005 Aug;252(8):944-52
pubmed: 15750701
Clin Neurophysiol. 2015 Apr;126(4):803-9
pubmed: 25227219
PLoS One. 2013 Dec 31;8(12):e85190
pubmed: 24391997
Electroencephalogr Clin Neurophysiol. 1990 Dec;76(6):509-19
pubmed: 1701119
Trends Neurosci. 2002 Jul;25(7):370-6
pubmed: 12079766
Front Hum Neurosci. 2019 Mar 20;13:100
pubmed: 30949041
J Neurol Neurosurg Psychiatry. 2019 Jul;90(7):729
pubmed: 30910859
PLoS One. 2016 Jun 20;11(6):e0157443
pubmed: 27322194
J Clin Neurol. 2013 Apr;9(2):65-74
pubmed: 23626643
Proc R Soc Lond B Biol Sci. 1987 Jul 22;231(1263):147-68
pubmed: 2889209
Exp Brain Res. 2006 Jul;172(3):361-9
pubmed: 16463149
Clin Neurophysiol. 2018 Jul;129(7):1479-1489
pubmed: 29678369
Brain Sci. 2021 Feb 27;11(3):
pubmed: 33673524
J Physiol. 2017 Apr 15;595(8):2715-2730
pubmed: 27891607
Front Hum Neurosci. 2014 Sep 22;8:719
pubmed: 25294995
J Neurol Neurosurg Psychiatry. 2019 Apr;90(4):404-411
pubmed: 30361295
Muscle Nerve. 2014 Jun;49(6):836-44
pubmed: 24037729
Hum Brain Mapp. 2011 May;32(5):750-8
pubmed: 20836159
Eur Radiol. 2015 Sep;25(9):2584-92
pubmed: 25875284
J Neurophysiol. 2002 Jul;88(1):124-32
pubmed: 12091538
Stroke. 2001 Nov;32(11):2597-601
pubmed: 11692023
Amyotroph Lateral Scler Other Motor Neuron Disord. 2000 Jun;1 Suppl 2:S23-32
pubmed: 11464937
Neurobiol Aging. 2013 Feb;34(2):419-27
pubmed: 22608240
Neurology. 2003 Dec 9;61(11):1619-20
pubmed: 14663056
J Neurol Neurosurg Psychiatry. 2018 Nov;89(11):1220-1221
pubmed: 29353238
Amyotroph Lateral Scler Frontotemporal Degener. 2016 Oct - Nov;17(7-8):561-570
pubmed: 27087114
J Neurol Neurosurg Psychiatry. 2013 Sep;84(9):969-72
pubmed: 23467416
J Physiol. 2001 Dec 1;537(Pt 2):651-6
pubmed: 11731595
Electroencephalogr Clin Neurophysiol. 1995 Feb;97(1):49-54
pubmed: 7533721
J Neurol Sci. 2000 Nov 1;180(1-2):66-70
pubmed: 11090867
J Neurol Neurosurg Psychiatry. 2012 Apr;83(4):399-403
pubmed: 22100761
Hum Brain Mapp. 2013 Oct;34(10):2391-401
pubmed: 22461315
Acta Neuropathol. 2017 Jan;133(1):79-90
pubmed: 27757524
Front Neurosci. 2016 May 10;10:204
pubmed: 27242409
PLoS One. 2012;7(4):e35241
pubmed: 22529995
J Neurol Neurosurg Psychiatry. 1992 Jan;55(1):20-4
pubmed: 1312579
Amyotroph Lateral Scler Frontotemporal Degener. 2014 Jun;15(3-4):250-6
pubmed: 24555863
Amyotroph Lateral Scler Frontotemporal Degener. 2021 Aug;22(5-6):380-387
pubmed: 33620270
Hum Brain Mapp. 2017 Jan;38(1):237-254
pubmed: 27623516
Exp Brain Res. 2003 May;150(2):222-9
pubmed: 12677319
Amyotroph Lateral Scler Frontotemporal Degener. 2013 May;14(4):315-8
pubmed: 23121291
J Neurol Neurosurg Psychiatry. 2017 Nov;88(11):917-924
pubmed: 28710326
Brain Res Bull. 2006 May 15;69(5):489-94
pubmed: 16647577
Muscle Nerve. 2005 Sep;32(3):261-79
pubmed: 15806550
Sci Rep. 2020 Sep 24;10(1):15661
pubmed: 32973334
Neurorehabil Neural Repair. 2007 Nov-Dec;21(6):518-26
pubmed: 17476000
J Clin Neurophysiol. 1999 Nov;16(6):501-11
pubmed: 10600018
Amyotroph Lateral Scler Frontotemporal Degener. 2018 May;19(3-4):232-241
pubmed: 29214883
Brain Sci. 2021 May 12;11(5):
pubmed: 34066053
Exp Neurol. 2009 May;217(1):147-53
pubmed: 19416664
J Neurol Neurosurg Psychiatry. 2019 Jul;90(7):730-733
pubmed: 30846542
Front Neurosci. 2019 May 08;13:371
pubmed: 31133773
Cereb Cortex. 2019 Jan 1;29(1):27-41
pubmed: 29136131
Front Neurol. 2019 Jan 08;9:1148
pubmed: 30671016
Brain Behav. 2021 Dec;11(12):e2403
pubmed: 34710283
Eur J Neurol. 2016 Aug;23(8):1361-71
pubmed: 27207250
PLoS One. 2015 Apr 17;10(4):e0119862
pubmed: 25885533
Elife. 2014 Oct 14;3:
pubmed: 25313866
Front Hum Neurosci. 2013 Jun 10;7:251
pubmed: 23772210
J Physiol Paris. 2008 Jan-May;102(1-3):21-30
pubmed: 18440209
Proc Natl Acad Sci U S A. 2009 Jan 20;106(3):918-23
pubmed: 19139417
Neuroscientist. 2003 Jun;9(3):195-204
pubmed: 15065815
J Neurol. 2007 Sep;254(9):1260-7
pubmed: 17385077
Neuroimage Clin. 2019;24:102054
pubmed: 31711033
J Neurol Neurosurg Psychiatry. 2017 May;88(5):369-370
pubmed: 27913627
Neuroimage. 2007 Jan 15;34(2):702-13
pubmed: 17112742
Muscle Nerve. 2014 Apr;49(4):469-77
pubmed: 24273101
J Physiol. 2012 May 15;590(10):2443-52
pubmed: 22393252
Amyotroph Lateral Scler Frontotemporal Degener. 2019 Nov;20(7-8):562-567
pubmed: 31364874
J Neurol Neurosurg Psychiatry. 2020 Sep;91(9):991-998
pubmed: 32665323
Front Aging Neurosci. 2018 Jul 17;10:215
pubmed: 30065647
Eur J Neurol. 2020 Jan;27(1):121-128
pubmed: 31310452
Neurol Sci. 2017 May;38(5):755-760
pubmed: 28150100
Brain Imaging Behav. 2010 Jun;4(2):121-31
pubmed: 20502995
Curr Opin Neurol. 2018 Aug;31(4):431-438
pubmed: 29750730
J Neurol Neurosurg Psychiatry. 2019 Apr;90(4):387-394
pubmed: 30355607
PLoS One. 2012;7(9):e45470
pubmed: 23029031
J Neurol Neurosurg Psychiatry. 2012 Jun;83(6):659-62
pubmed: 22496581
Exp Brain Res. 1982;47(1):33-40
pubmed: 6288432
Neurotherapeutics. 2017 Jan;14(1):78-90
pubmed: 27878516
Muscle Nerve. 2000 Jan;23(1):138
pubmed: 10590421
Front Neurol. 2019 May 29;10:565
pubmed: 31191446
Exp Brain Res. 1992;89(3):649-54
pubmed: 1644127